Hugh Cole - Insider Trading & Ownership

Location
C/O Ariad Pharmaceuticals, Inc, 26 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Hugh Cole is at least $204K dollars as of June 12, 2025. Hugh Cole is the Chief Operating Officer of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $204K.
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Hugh Cole
All Insider Reports
All Insider Reports

Ownership of Hugh Cole

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JNCE Jounce Therapeutics, Inc. Chief Operating Officer $204K Jan 9, 2023
ATXS Astria Therapeutics, Inc. Director Jun 11, 2025

Insider Transactions Reported by Hugh Cole:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.